title: Precision medicine to improve the risk and benefit of cancer care: genetic factors in vincristine-related neuropathy.
authors.affiliation: DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida2Xiangya Hospital, Institute of Clinical Pharmacology, Central South University, Changsha, China.
authors.forename: Howard L
authors.initials: HL
authors.lastname: McLeod
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008869:Microtubule-Associated Proteins / Q000235:genetics*; D010523:Peripheral Nervous System Diseases / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D014750:Vincristine / Q000009:adverse effects*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; C542475:CEP72 protein, human; D008869:Microtubule-Associated Proteins; D014750:Vincristine